Drug Markets/Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide

Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide

5 NDCs across 1 manufacturer|5 Generic,0 Brand

▸ More about this market

Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide is available as 5 NDCs from 1 manufacturer (5 generic, 0 brand), with NADAC prices from $0.78 to $1.15 per EA — a 48% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

5

5G / 0B

Manufacturers

1

competing in market

Price Spread

$0.78 – $1.15

per EA

7d Activity

12↑8↓-15 flat

avg +0.5% WoW · of 5 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE

Frequently Asked Questions

How many Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide products are on the market?

The Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide drug market contains 5 NDCs from 1 manufacturer — 5 generic and 0 brand products.

What is the price range for Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide?

NADAC reference prices for Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide range from $0.7762 to $1.1514 per EA — a 48% difference between cheapest and most expensive.

Which manufacturers make Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide?

1 manufacturer lists Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide in NADAC. Ranked by number of NDCs, the largest are Slate Run Pharmaceuticals LLC (5).

How has the price of Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide changed recently?

Over the past 7 days, 12 Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide NDCs rose and 8 fell, with a market-wide average change of +0.5%.